Evaluate a Norstella company
Evaluate a Norstella company

Resources

Resource Centre

Looking for the latest from the Evaluate team? Below you’ll find our latest blogs, reports, webinars and more. Whether you’re looking for detailed analysis of the state of the biopharma market, or a quick primer on a particular topic, you’re in the right place.

On Demand Webinar

Inside #JPM2026:

The Stories Behind the Summit

Watch Now
Content Type
Topic

Most Recent

finding-her-niche-in-forecasting---and-finding-answers-for-clients
Finding her niche in forecasting — and finding answers for clients
Expert Interviews
April 16, 2026
In this series, Citeline and Evaluate consulting team members discuss some of the key challenges that face the companies they work with across...
Kelly Chamberlain Competitive Intelligence
Meet the Team: Kelly Chamberlain
Blog
April 15, 2026
Kelly Chamberlain has been with Norstella, Evaluate’s parent company as Partner, Market Intelligence since 2024. She’s an expert in supporting...
Business financial chart with moving up arrow graph.Financial data charts with glowing stock market graphs.Stock market investment data and analysis finance graph
2025 Deal-making Roundup Infographic
Infographic
April 13, 2026
Biopharma deal-making rebounded strongly in 2025, with rising confidence, larger transactions, and record alliance values shaping the year. Our...
thumn-wp26-mj
World Preview 2026 Webinar
Webinar
April 2, 2026
The top-selling drugs and companies in 2032 The therapy areas driving growth Top pipeline products and the blockbusters of the future The continuing...
BIO-Europe Spring Therapy Area Panel
BIO-Europe Spring: Pharma Dealmaking in Lisbon
Blog
March 31, 2026
CNS may finally be emerging from its long discussed graveyard. Oncology dealmaking is becoming more selective. And sourcing innovation from China...
providing-unbiased-pharma-market-research-fi
Providing unbiased pharma market research to inform business decisions
Expert Interviews
March 30, 2026
In this series, Citeline and Evaluate’s consulting team members discuss some of the key challenges that face the companies they work with across...
thumb-5
Highlights of the Orphan Drugs Report by its Creators
Video Blog
March 30, 2026
For the past few years, Melanie Senior and Andreas Hadjivasiliou have worked together to deliver Evaluate’s annual Orphan Drugs report. They...
andreas-video-blog-fi4x
How We Build the Analysis Behind Our Orphan Drugs Report
Video Blog
March 30, 2026
How do we Create the Analysis for our Orphan Drugs Report? Insight is the cornerstone of our annual orphan drugs report, and all that insight...
sizing-up-the-marketplace-01
Sizing Up the Marketplace
Expert Interviews
March 24, 2026
In this series, the consulting teams at Citeline and Evaluate discuss some of the key challenges that face the companies they work with across...
2025-review-capitals-better
2025 Review: Capital’s Better
Report/eBook
March 20, 2026
Biopharma capital returned in 2025. But not for everyone. After a significant dry spell, capital began to flow back into biopharma in 2025. Though...
Three Things we Learned in our 2026 Orphan Drugs Webinar
Three Things we Learned in our 2026 Orphan Drugs Webinar
Blog
March 20, 2026
Orphan drugs are forecast to make up 21% of all prescription drug sales by 2032, according to Evaluate forecasts. So it’s hardly surprising that...
pressure-testing-ambition
Pressure testing ambition: Why Target Product Profiles Matter More Than Ever
Expert Interviews
March 18, 2026
In this series, Evaluate’s consultants discuss some of the key challenges that face the companies they work with across the pharma space. In...
Load More

Upcoming Webinars / View On Demand

Webinars

Looking to learn? Our webinar series brings together Evaluate’s experts with industry leaders to talk about the big issues of the day.

Learn more

News / Events / Press Releases

News & Events

Check out the latest news from Evaluate and find out where you can come to meet the team.

Learn more

Data-driven Reports / Infographics / Articles

Thought Leadership

Catch up with our insights on the big issues in pharma.

Learn more
Evaluate White Logo
Instagram Linkedin